Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2022-12-16 (3 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CHAMPIGNY-SUR-MARNE (94500), Val-de-Marne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE AL BOUNNI : revenue, balance sheet and financial ratios
SELARL PHARMACIE AL BOUNNI is a French company
founded 3 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CHAMPIGNY-SUR-MARNE (94500),
this company of category PME
shows in 2024 a net income positive of 69 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE AL BOUNNI (SIREN 922560263)
Indicator
2024
2023
Revenue
N/C
N/C
Net income
69 431 €
-372 €
EBITDA
N/C
N/C
Net margin
N/C
N/C
Revenue and income statement
In 2024, SELARL PHARMACIE AL BOUNNI generates positive net income of 69 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
69 431 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 554%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 11%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
554.292%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
11.255%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE AL BOUNNI
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2023
2024
Debt ratio
4755.775
554.292
Financial autonomy
1.439
11.255
Repayment capacity
None
None
Cash flow / Revenue
None%
None%
Sector positioning
Debt ratio
554.292024
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average
In 2024, the debt ratio of SELARL PHARMACIE AL BOUNNI (554.29) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
11.26%2024
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch
In 2024, the financial autonomy of SELARL PHARMACIE AL BOUNNI (11.3%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 156.54. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
156.542
Liquidity indicators evolution SELARL PHARMACIE AL BOUNNI
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2023
2024
Liquidity ratio
128.826
156.542
Interest coverage
None
None
Sector positioning
Liquidity ratio
156.542024
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Average+14 pts over 2 years
In 2024, the liquidity ratio of SELARL PHARMACIE AL BOUNNI (156.54) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of SELARL PHARMACIE AL BOUNNI in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELARL PHARMACIE AL BOUNNI is estimated at
969 308 €
(range 675 010€ - 1 450 140€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
675k€969k€1450k€
969 308 €Range: 675 010€ - 1 450 140€
NAF 5 année 2024
Valuation method used
Net Income Multiple
69 431 €
×
14.0x
=969 308 €
Range: 675 011€ - 1 450 140€
Only this financial indicator is available for this company.
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE AL BOUNNI with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE AL BOUNNI
What is the revenue of SELARL PHARMACIE AL BOUNNI ?
The revenue of SELARL PHARMACIE AL BOUNNI is not publicly disclosed (confidential accounts filed with INPI).
Is SELARL PHARMACIE AL BOUNNI profitable?
Yes, SELARL PHARMACIE AL BOUNNI generated a net profit of 69 k€ in 2024.
Where is the headquarters of SELARL PHARMACIE AL BOUNNI ?
The headquarters of SELARL PHARMACIE AL BOUNNI is located in CHAMPIGNY-SUR-MARNE (94500), in the department Val-de-Marne.
Where to find the tax return of SELARL PHARMACIE AL BOUNNI ?
The tax return of SELARL PHARMACIE AL BOUNNI is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE AL BOUNNI operate?
SELARL PHARMACIE AL BOUNNI operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart